Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers - Rothenberg, Michael E.; Tagen, Michael; Chang, Jae H.; Boyce-Rustay, Janel; Friesenhahn, Michel; Hackos, David H.; Hains, Avis; Sutherlin, Dan; Ward, Michael; Cho, William (Clinical drug investigation, 2019)
Keywords: Drug dosages; Inhibitor drugs; Internal Medicine; Medicine; Medicine & Public Health; Mutation; Narcotics; Nonsteroidal anti-inflammatory drugs; Original Research Article; Pain; Pharmacokinetics; Pharmacology/Toxicology; Pharmacotherapy; Vital signs; United States--US